Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER in OA Knee Pain
NCT00421928Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tapentadol in knee osteoarthritis (OA), sponsored by Johnson & Johnson. Started Jan 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00421928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421928.